trending Market Intelligence /marketintelligence/en/news-insights/trending/LrTtTpGr2L1EeBOHz_khkw2 content esgSubNav
In This List

CohBar appoints director

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Insight Weekly: Labor market struggles; solar demand remains strong; banks' deposit holdings


CohBar appoints director

CohBar Inc. appointed John Amatruda to the board.

Amatruda is a co-founder and scientific adviser to the company. He is also currently on the board of CureDM, Prosciento, and Fractyl.

CohBar is a biotechnology company focused on the research and development of mitochondria-based therapeutics for age-related diseases.